Pharming Group N.V. announced the appointment of Kenneth Lynard as Chief Financial Officer, effective October 1, 2025. His extensive experience in the life sciences industry is expected to strengthen the company's financial leadership.
Who to call at Pharming Group, and when
A new leader at Pharming Group brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Pharming Group raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Pharming Group, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pharming Group. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Pharming Group
Location
Leiden, South Holland, Netherlands
About
Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pharming Group changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
LeidenBiotechnologyHealth CareTherapeuticsPharmaceutical